ReNeuron Group (LSE:RENE) 5-Year EBITDA Growth Rate : 29.10% (As of Sep. 2023)

View and export this data going back to 2005. Start your Free Trial

What is ReNeuron Group 5-Year EBITDA Growth Rate?

ReNeuron Group's EBITDA per Share for the six months ended in Sep. 2023 was £-0.05.

During the past 3 years, the average EBITDA Per Share Growth Rate was 35.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 29.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of ReNeuron Group was 35.70% per year. The lowest was -22.80% per year. And the median was 18.30% per year.

Competitive Comparison of ReNeuron Group's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, ReNeuron Group's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ReNeuron Group's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's 5-Year EBITDA Growth Rate falls into.

ReNeuron Group 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

ReNeuron Group (LSE:RENE) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

ReNeuron Group 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group (LSE:RENE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

RNUGF:USA RENE.GB:UK RQE1:Germany

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.